Related Experiment Video
Updated: Mar 7, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Quality Measure Adherence in Parkinson's Disease: A Single Center Experience***Parkinson's Disease Quality Measures
Tanner Bradford1, Bryanna De Lima2, Kahley Milauskas2
1School of Medicine, Oregon Health & Science University, Portland, OR, USA.
Background:
Patients with Parkinson's Disease (PWPs) often have both motor and non-motor manifestations requiring specialized care. Neurologists typically lead their care; however, the population of PWPs is exceeding the supply of neurologists. Primary care providers (PCPs) may need to contribute to improve care.
Objective:
To measure American Academy of Neurology quality metric (QM) adherence between neurologists and PCPs for PWPs.
Methods:
We conducted a single-center retrospective, descriptive analysis assessing 14 QMs in the past year for PWPs established with a neurologist and PCP. McNemar's test assessed statistical differences between groups. Logistic regression models explored the impact of age, sex, and visit frequency on QM adherence.
Results:
On average, 8.9 QMs were addressed among 89 PWPs. Motor complications, rehabilitation referrals, falls, and autonomic dysfunction were the most often addressed while apathy and impulse control disorder were the least. Neurologists alone met motor complications, psychosis, impulse control disorder, and sleep disturbance significantly more than PCPs alone while PCPs assessed depression and advance care planning more often. PCP involvement improved adherence throughout. Depression, apathy, and advance care planning metric adherence were significantly impacted by age and/or visit frequency.
Conclusions:
A team-based approach to quality metric adherence may reduce the burden on providers and improve care for PWPs.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease: Overview
Neural Regulation
Drug Therapy
Antianxiety Medications

